T

Theravance Biopharma
D

TBPH

9.41000
USD
0.05
(0.53%)
مفتوح الان
حجم التداول
1,007
الربح لكل سهم
1
العائد الربحي
-
P/E
-9
حجم السوق
462,730,125
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALKS
    1.390
    (4.60%)
    31.610 USD
    C
    CRBP
    -0.360
    (-3.17%)
    10.990 USD
    F
    FOLD
    0.06000
    (0.63%)
    9.60500 USD
    G
    GLPG
    -0.170
    (-0.71%)
    23.750 USD
    I
    INSM
    -0.120
    (-0.15%)
    78.330 USD
    P
    PTCT
    1.040
    (2.31%)
    46.140 USD
    S
    SAGE
    0.00500
    (0.07%)
    7.03000 USD
    S
    SRPT
    1.250
    (1.08%)
    117.270 USD
    المزيد
الأخبار
المقالات

العنوان: Theravance Biopharma

القطاع: Healthcare
الصناعة: Biotechnology
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).